Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research on Anomaly Detection of Surveillance Video Based on Branch-Fusion Net and CSAM. | Sensors (Basel) | 2023 | 36772423 | PubTator, text mining | PubMed |
| Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I. | Molecules | 2023 | 36771105 | PubTator, text mining | PubMed |
| Survivin Small Molecules Inhibitors: Recent Advances and Challenges. | Molecules | 2023 | 36771042 | PubTator, text mining | PubMed |
| Roles of G4-DNA and G4-RNA in Class Switch Recombination and Additional Regulations in B-Lymphocytes. | Molecules | 2023 | 36770824 | PubTator, text mining | PubMed |
| K2CO3-Promoted Formal [3+3]-Cycloaddition of N-Unsubstituted Isatin N,N'-Cyclic Azomethine Imine 1,3-Dipoles with Knoevenagel Adducts. | Molecules | 2023 | 36770700 | PubTator, text mining | PubMed |
| Systemically Identifying Triple-Negative Breast Cancer Subtype-Specific Prognosis Signatures, Based on Single-Cell RNA-Seq Data. | Cells | 2023 | 36766710 | PubTator, text mining | PubMed |
| Ribosome biogenesis factors-from names to functions. | EMBO J | 2023 | 36762427 | PubTator, text mining | PubMed |
| APE2: catalytic function and synthetic lethality draw attention as a cancer therapy target. | NAR Cancer | 2023 | 36755963 | PubTator, text mining | PubMed |
| Turning Red without Feeling Embarrassed─Xanthenium-Based Photocages for Red-Light-Activated Phototherapeutics. | J Am Chem Soc | 2023 | 36752773 | PubTator, text mining | PubMed |
| The chromatin-associated RNAs in gene regulation and cancer. | Mol Cancer | 2023 | 36750826 | PubTator, text mining | PubMed |
| Hypoxia-associated circPRDM4 promotes immune escape via HIF-1α regulation of PD-L1 in hepatocellular carcinoma. | Exp Hematol Oncol | 2023 | 36747292 | PubTator, text mining | PubMed |
| Signal-induced enhancer activation requires Ku70 to read topoisomerase1-DNA covalent complexes. | Nat Struct Mol Biol | 2023 | 36747093 | PubTator, text mining | PubMed |
| SpliceVault predicts the precise nature of variant-associated mis-splicing. | Nat Genet | 2023 | 36747048 | PubTator, text mining | PubMed |
| Synthetic lethal targeting of TET2-mutant haematopoietic stem and progenitor cells by XPO1 inhibitors. | Br J Haematol | 2023 | 36746437 | PubTator, text mining | PubMed |
| Inspired by bis-β-carboline alkaloids: Construction and antitumor evaluation of a novel bis-β-carboline scaffold as potent antitumor agents. | Bioorg Chem | 2023 | 36746025 | PubTator, text mining | PubMed |
| Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer. | Front Genet | 2023 | 36741321 | PubTator, text mining | PubMed |
| Determination of the synergistic anti-influenza effect of Huangqin Su tablet and Oseltamivir and investigation of mechanism of the tablet based on gut microbiota and network pharmacology. | BMC Complement Med Ther | 2023 | 36739385 | PubTator, text mining | PubMed |
| Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1. | Signal Transduct Target Ther | 2023 | 36732502 | PubTator, text mining | PubMed |
| Two distinct long-range synaptic complexes promote different aspects of end processing prior to repair of DNA breaks by non-homologous end joining. | Mol Cell | 2023 | 36724784 | PubTator, text mining | PubMed |
Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues. | PeerJ | 2023 | 36721777 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=36